IL-1β levels in saliva of patients with psoriasis were significantly higher than in healthy controls. In patients with psoriasis, TNF-α inhibitor treatment significantly reduced IL-1β levels, compared with baseline. There is a positive correlation between IL-1β levels and psoriasis activity. Here, IL1B is linked to psoriasis.